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Abstract
Objective: Androgen excess in childhood is a common presentation and may signify sinister underlying pathology. Data 
describing its patterns and severity are scarce, limiting the information available for clinical decision processes. Here, 
we examined the differential diagnostic value of serum DHEAS, androstenedione (A4) and testosterone in childhood 
androgen excess.
Design: Retrospective review of all children undergoing serum androgen measurement at a single center over 5 years.
Methods: Serum A4 and testosterone were measured by tandem mass spectrometry and DHEAS by immunoassay. 
Patients with at least one increased androgen underwent phenotyping by clinical notes review.
Results: In 487 children with simultaneous DHEAS, A4 and testosterone measurements, we identified 199 with 
androgen excess (140 pre- and 59 post-pubertal). Premature adrenarche (PA) was the most common pre-pubertal 
diagnosis (61%), characterized by DHEAS excess in 85%, while A4 and testosterone were only increased in 26 and 9% 
respectively. PCOS was diagnosed in 40% of post-pubertal subjects, presenting equally frequent with isolated excess of 
DHEAS (29%) or testosterone (25%) or increases in both A4 and testosterone (25%). CAH patients (6%) predominantly 
had A4 excess (86%); testosterone and DHEAS were increased in 50 and 33% respectively. Concentrations increased 
above the two-fold upper limit of normal were mostly observed in PA for serum DHEAS (>20-fold in the single case of 
adrenocortical carcinoma) and in CAH for serum androstenedione.
Conclusions: Patterns and severity of childhood androgen excess provide pointers to the underlying diagnosis and can 
be used to guide further investigations.
Introduction
Androgen excess in childhood may present with a variety 
of symptoms and is thought to have a broad spectrum of 
underlying pathologies (1). Premature pubic and axillary 
hair growth, change in body odor and transient growth 
acceleration are typical presenting signs in pre-pubertal 
children (2); menstrual disturbances with hirsutism 
are presenting features in post-pubertal girls (3). In the 
vast majority of affected pre-pubertal children, PA is the 
underlying diagnosis, whereas adolescent polycystic ovary 
syndrome (PCOS) is the leading cause of androgen excess 
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in pubertal girls after menarche (1, 2, 4). Importantly, 
the diagnosis of PA and PCOS require exclusion of other 
causes of androgen excess such as inborn steroidogenic 
enzyme defects, most commonly congenital adrenal 
hyperplasia (CAH), precocious puberty or potentially 
malignant virilizing adrenal tumors, with the latter being 
extremely rare in childhood (1, 5, 6).
To reach a conclusive diagnosis in a child presenting 
with androgen excess can be challenging. Detailed history, 
including onset, acuity, severity and progression of 
symptoms and a thorough clinical examination, followed 
by hormonal investigations, bone age assessment, 
and, where appropriate, imaging studies, are part of 
the clinical work-up (1, 7). The extent of investigations 
required usually depends on the severity and acuity of 
presenting symptoms, and clinicians tend to tailor those 
investigations depending on the clinical presentation 
and the severity of biochemical androgen excess (7). 
However, there is a paucity of data from larger cohorts 
delineating patterns and severity of childhood androgen 
excess considered predictive for both common and rare 
underlying pathologies.
Physiologically low circulating androgen levels in 
children and the widespread use of radioimmunoassays, 
which are prone to cross-reactivity and low sensitivity, 
limit the diagnostic accuracy of the measurement of the 
serum concentrations of the active androgen testosterone 
and the androgen precursors androstenedione (A4) and 
DHEAS, in particular when measured in isolation (8, 
9). Liquid chromatography–tandem mass spectrometry 
(LC–MS/MS) analysis of serum steroids has emerged as 
a highly sensitive analytical tool, in particular when 
measuring low-abundance steroids in children (10, 11). 
To date, there is a dearth of data on LC–MS/MS-based 
androgen measurements in childhood androgen excess 
conditions.
We have recently reported the utility of simultaneous 
measurement of serum DHEAS, A4 and testosterone in 
determining causes, patterns and severity of androgen 
excess in a large sample of adult women recruited in 
a single center (12), generating useful guidance for 
clinicians to predict non-PCOS pathology in adult 
women presenting with androgen excess. In this study, 
we aimed to develop the evidence base for a rational 
approach to childhood androgen excess. To this end, 
we analyzed a large cohort of consecutively recruited 
children from a single tertiary referral center to uncover 
the signatures of distinct conditions underlying 
childhood androgen excess.
Patients and methods
Subjects and clinical protocol
Institutional review board approval for retrospective 
data review was obtained from Birmingham Women’s 
and Children’s Hospital (BWCH) NHS Foundation Trust 
(reference: CARMS-00935). We included all children who 
had undergone measurements of serum testosterone, 
A4 and DHEAS as part of routine clinical care at 
BWCH between 1st January 2013 and 1st June 2017 
(n = 1525), identifying 487 who underwent simultaneous 
measurement of DHEAS, A4 and testosterone. Samples 
were collected at variable times during the day in the 
context of outpatient clinic appointments. Patients with 
at least one serum androgen concentration increased 
above the Tanner stage-specific reference range (n = 199) 
underwent further clinical phenotyping by case note 
review, extracting information on clinical presentation, 
medical history, height, weight, BMI, bone age, ethnicity 
and the underlying cause of androgen excess, as supported 
by clinical, biochemical and radiological findings in 
each case with final review by a board-certified pediatric 
endocrinologist (V S, T G B, N J S, N K, R P D, M K, J K, W 
H, R E K). Reference data for standardized BMI (BMI SDS) 
were obtained from the British 1990 dataset (13).
Serum androgen measurements
Biochemical androgen excess was defined as a serum 
concentration increased above a local, age-specific 
reference range (for DHEAS) or above the Tanner stage-
specific normative reference range as reported in 14 for A4 
and testosterone. Serum A4 and testosterone were analyzed 
by liquid chromatography–tandem mass spectrometry on 
a Shimadzu Prominence XR UPLC coupled to a Sciex 6500 
Triple Quad mass spectrometer as described previously (12). 
Briefly, samples are analyzed by liquid–liquid extraction 
following addition of deuterated internal standards and 
separated chromatographically using an isocratic elution 
profile, ionized using positive atmospheric pressure 
chemical ionization and detected according to compound-
specific transitions. Serum DHEAS was analyzed using the 
Roche competitive electrochemiluminescence immunoassay 
on the Roche Cobas c702 analyzer (12).
Statistical analysis
GraphPad Prism was used for statistical analysis and 
generation of graphs. Data were expressed as median 
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and first and third quartile, unless otherwise stated. 
The Mann–Whitney U test was used for comparison 
between two groups (pre- and post-pubertal). Spearman 
rank correlation was employed to assess correlation 
between two non-evenly distributed variables. Statistical 
significance was set at P < 0.05.
Results
Description of the cohort and diagnostic spectrum
A total of 1525 children had at least one serum 
concentration of DHEAS, A4 or testosterone measured 
during the study period. In 487 children (31.9%), all 
three androgens had been measured simultaneously and 
were taken forward as the analysis cohort (Fig. 1). When 
applying age-defined cut-offs, 255 children (52.4%) had 
at least one increased serum androgen; however, when 
applying Tanner stage-defined cut-offs, thus taking into 
account pubertal development, only 199 children (40.9%) 
had androgen excess (Fig.  1). Those 199 children were 
phenotypically further characterized as described in the 
‘Methods’ section. There was a pre-dominance of girls 
(Table  1). The median BMI SDS was increased in the 
overall cohort and higher in the pubertal than in the 
pre-pubertal group (Table  1). The overall cohort was 
ethnically diverse, with the two largest group comprising 
Caucasian children (44.2%) and children of South Asian 
ethnicity (38.7%) (Table 1).
The overall majority of pre-pubertal children had a 
diagnosis of PA (n = 86; 61%), while at pubertal age, PCOS 
was the most common diagnosis (n = 24; 40%) (Fig.  1). 
In both subgroups, rare and very rare underlying causes 
of androgen excess were also identified, including CAH 
(7.0%), isolated premature menarche (IPM; 2.5%), central 
precocious puberty (cPP; 2.5%) and one case each of 
adrenocortical carcinoma (ACC) and Cushing’s disease 
(CD). In about one third of cases, miscellaneous diagnoses 
and features were reported or no associated diagnosis was 
made (Fig. 1 and Supplementary Table 1, see section on 
supplementary data given at the end of this article).
The majority of the 86 children with PA were 
girls (79%). Girls with PA presented at a median age of 
7.2 years, boys at 8.2 years. Forty-one PA children (48%) 
were of Caucasian ethnicity, 31 children (26%) of South-
Asian and 12 children (14%) of Afro-Caribbean descent; 
the general population in the local area has been recorded 
as 58.0% Caucasian, 22.5% South Asian and 9% Afro-
Caribbean (15). There were no notable gender differences 
with regards to clinical presentation (Supplementary 
Table 2), although acne was rare in boys. The median bone 
age advancement in the PA cohort was 1.88  years 
(IQR: 1.16, 2.33). None of the subjects had notable 
co-morbidities or were on any regular medication.
In subjects diagnosed with adolescent PCOS, the 
median age at presentation was 15.2  years (IQR: 13.1, 
15.7). The majority was of South-Asian ethnicity (n = 18; 
75%); three were Caucasian (12.5%) and two girls were 
African-Caribbean (8%). The diagnosis of PCOS was 
established on the basis of the presence of an irregular 
menstrual cycle and biochemical features of androgen 
excess. In addition, 63% (n = 15) girls also had clinical 
signs of androgen excess (hirsutism and/or acne) and 
seven subjects complained about weight gain (29%). The 
median BMI of the PCOS subjects was 27.1 kg/m2 (2.24 
SDS; IQR: 0.91, 2.58). None of the PCOS subjects had 
significant co-morbidities, and they were not on any anti-
androgenic medication or metformin at presentation.
All 14 CAH patients had a genetically confirmed 
diagnosis of 21-hydroxylase (CYP21A2) deficiency; 12 had 
Figure 1
Flowchart of the distribution of diagnoses according to 
pre-pubertal vs post-pubertal status in 487 children who 
underwent simultaneous measurement of serum DHEAS, A4 
and testosterone. ACC, adrenocortical carcinoma; CAH, 
congenital adrenal hyperplasia; CD, Cushing’s disease; cPP, 
central precocious puberty; IPM, isolated premature menarche; 
PA, premature adrenarche; PCOS, polycystic ovary syndrome.
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the classic salt-wasting form and two subjects had non-classic 
CAH. All classic CAH cases were on steroid replacement 
therapy; the non-classic cases were not on medication.
We identified five girls with IPM and five with central 
precocious puberty (cPP). All IPM cases presented with 
isolated vaginal bleeding. All girls with cPP presented 
with early breast development and additional signs 
of androgen excess (premature pubarche n = 4; early 
development of axillary hair n = 3; acne n = 2). In 
extremely rare cases, one boy presented with ACC and 
one boy with CD. The ACC case presented at the age 
of 1.8  years with peripheral precocious puberty. The 
boy with CD presented at 13  years of age with weight 
gain, easy bruising, headaches and typical Cushingoid 
appearance and was found to have an ACTH-producing 
pituitary micro-adenoma.
Patterns of androgen excess according to the 
underlying diagnosis
Isolated DHEAS excess was the most common biochemical 
presentation in children presenting with PA (n = 58; 67.4%) 
(Fig. 2A). Eleven PA subjects (12.8%) had a combination 
of DHEAS and A4 excess. Isolated A4 or testosterone 
excess was rare in PA and only found in nine (10.5%) and 
four (4.7%) subjects. A pattern with all three androgens 
elevated was only observed in three PA subjects (3.5%). 
In adolescent PCOS, patients equally frequently presented 
with isolated DHEAS excess (29%), isolated testosterone 
excess (25%) or increased serum concentrations of both 
A4 and testosterone (25%) (Fig. 2B).
Children with CAH predominantly presented with 
A4 excess (86%); testosterone and DHEAS were increased 
in 50 and 33% respectively (Fig.  2C). Isolated DHEAS 
was never observed in CAH children, and only one pre-
pubertal CAH patient presented with isolated testosterone 
excess and increases in all three androgens respectively. 
In the ACC case, both DHEAS and A4 were increased, and 
the CD case had isolated A4 excess.
Severity of androgen excess
In children with PA, serum DHEAS was mostly increased 
one to two-fold above the upper limit of normal (ULN) and 
did not exceed eight-fold ULN (Fig. 3A and Supplementary 
Table 3). PA girls had higher DHEAS than boys (P = 0.036) 
(Supplementary Fig. 1 and Supplementary Table 3). The 
single ACC case presented with serum DHEAS increased 
to 28-fold ULN. The majority of children with CAH had 
normal DHEAS levels (Fig. 3A and Supplementary Table 3).
A4 excess above two-fold ULN was typically observed 
in classic CAH patients (Fig.  3B and Supplementary 
Table  3). Mild-to-moderate A4 excess (one- to two-fold 
ULN) was observed in adolescent PCOS (42%), in some 
children with PA (24%) and in the ACC case. The boy with 
CD had severe A4 excess. In PA, A4 was higher in boys 
than girls (P = 0.0008) (Supplementary Fig. 1).
Both mild-to-moderate (one- to two-fold ULN) and 
severe (>two-fold ULN) excess of serum testosterone was 
found in a number of subjects with PA, PCOS and CAH 
(Fig. 3C and Supplementary Table 3). Testosterone excess 
was found in a minority of children with PA (10%), 
Table 1 Baseline demographics of 199 children with biochemical androgen excess as defined by serum concentrations above 
the reference range for at least one of three measured androgens (DHEAS, androstenedione and testosterone).
Total Pre-pubertal Pubertal
Patients with ≥1 of 3 androgens increased 199 140 (70.3%) 59 (29.7%)
Age (years; median (Q1, Q3)) 8.3 (6.8, 13.3) 7.4 (4.6, 8.5) 14.9 (13.4, 15.6)
Gender (%)
 Girls 141 (70.8) 89 (63.6) 52 (88.1)
 Boys 58 (29.2) 51 (36.4) 7 (11.9)
BMI (kg/m2; median (Q1, Q3)) 19.5 (16.4, 25.1) 17.9 (15.9, 22.0) 26.8 (19.8, 31.0)
BMI SDS (median (Q1, Q3)) 1.35 (0.2, 2.6) 1.26 (−0.1, 2.5) 1.88 (0.6, 2.7)
Ethnicity* (%)
 Caucasian 91 (44.2) 64 (44.2) 27 (44.2)
 South Asian 76 (38.7) 50 (36.9) 26 (44.1)
 Afro-Caribbean 16 (8.0) 13 (9.4) 3 (4.9)
 Mixed background 3 (1.5) 2 (1.5) 1 (1.6)
 Other 1 (0.5) 0 1 (1.6)
 Unknown 13 (6.5) 11 (7.2) 3 (4.9)
United Kingdom Census 2011, Office for National Statistics (15).
*Ethnicity distribution pattern in the Birmingham area is: Caucasian 58.0%, Asian 26.6% (South Asians 22.5%, other Asians 4.08%), Afro-Caribbean 9.0%, 
mixed 4.4% and other 2.0%.
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but two boys had severe testosterone excess; overall, 
serum testosterone did not differ between boys and girls 
with PA (Supplementary Fig.  1). In PCOS, testosterone 
excess was found in 63% of cases, but was severe in one 
only (Fig.  3C). In classic CAH, six subjects (50%) had 
testosterone excess, which was severe (five-fold elevation) 
in one adolescent girl.
Discussion
Here, we have simultaneously measured the serum 
concentrations of the androgen precursors DHEAS and 
A4 as well as the active androgen testosterone in 487 
consecutively recruited children and adolescents in a single 
tertiary pediatric referral center, covering a population 
of 5.5 million. The size of our cohort, comprising 199 
children with biochemically confirmed androgen excess, 
enabled us to provide separate analyses of androgen 
excess pattern and severity in the pre- and post-pubertal 
age subgroups. Our study cohort included children 
presenting with clinical features of androgen excess, 
but also patients with suspicion of complex adrenal and 
gonadal pathologies, increasing the diverse and complex 
spectrum of underlying conditions. This enriched our 
study population for rare and very rare diagnoses. 
The study population was ethnically very diverse; in 
comparison to the local background population, there 
was some over-representation of South Asian and African-
Caribbean ethnicities in PA children and particular over-
representation of South-Asian ethnicity in the PCOS 
group. This may partially reflect the higher incidence of 
PCOS in South Asian subjects (16) as well as the proximity 
of our center to areas with higher ethnic diversity within 
the overall catchment area.
Previous studies have assessed serum androgens in 
pre-selected samples of children with distinct androgen 
excess conditions, mainly PA and adolescent PCOS. PA 
has been studied over the past 30 years in several case-
control studies, in well described cohorts consisting of 
10–100 study subjects of various ethnical–geographical 
backgrounds, but mainly focusing on metabolic 
consequences in PA ((1, 2, 17, 18) for comprehensive 
reviews), however, generally without providing full 
details on androgen metabolism including severity levels. 
Two studies reported immunoassay-based androgen 
concentrations in subjects with PA (19, 20). Virdis et al. 
Figure 2
Distribution of serum androgen excess patterns in (A) children 
with premature adrenarche, (B) girls with polycystic ovary 
syndrome and (C) children with congenital adrenal 
hyperplasia. White bars represent pre-pubertal subjects, black 
bars post-pubertal subjects.
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reported elevated DHEAS levels in the majority of subjects 
up to 9-fold above the upper limit of age-matched 
controls, but normal A4 and testosterone excess only in 
most subjects studied (19). Voutilainen et al. did not report 
DHEAS levels, but found that unconjugated DHEA and A4 
were up to 5-fold elevated in 18 PA subjects studied (20).
Adrenal androgen excess with elevated serum DHEAS 
above the age-specific reference range and a marginal 
increase in downstream androgens is recognized as a 
key feature of PA (2, 21); others suggested increased 
serum DHEAS appropriate for Tanner pubertal stage but 
increased when referring to age-specific reference ranges 
(22, 23). Of note, the pattern and severity of androgen 
excess in PA has not been analyzed in detail previously, 
neither how these differentiate PA from other conditions 
presenting with androgen excess such as CAH or other 
even rarer causes.
In our cohort, increased serum DHEAS was 
detected in the majority of children with PA while A4 
and testosterone were increased only in a minority of 
subjects, despite clinical evidence of increased androgen 
action. DHEAS is an inactive metabolite with no affinity 
to the androgen receptor, suggesting that downstream 
conversion of de-sulfated DHEA to potent androgens 
could occur within the target tissues of androgen 
action. Our group and others have recently highlighted 
11-oxygenated androgens as a major source of androgen 
excess in conditions like PCOS and CAH (24, 25, 26, 27). 
The adrenal P450 cytochrome 11β-hydroxylase 
(CYP11B1) enzyme efficiently converts A4 to 
11-hydroxy-androstenedione, which can be further 
converted to 11-ketotestosterone (11KT), which has 
been shown to bind and activate the androgen receptor 
with similar potency to testosterone (24, 28, 29). In 
fact, 11KT has very recently been shown to feature 
prominently in children with PA (30), supporting the 
theory that androgenic effects in PA may be mediated 
via increased 11-oxygenated androgens. However, 
measurement of 11-oxygenated androgens does not 
yet form part of routine androgen assessment in 
childhood androgen excess and, thus, was not measured 
in our cohort.
Radioimmunoassays (RIAs) were employed in 
the past in studies assessing androgen metabolism in 
children, in particular the initial reports from the 1970s 
(31, 32), which are frequently referenced. RIAs are prone 
to cross-reactivity and less sensitive to lower circulating 
concentrations usually found in children. Our study 
has employed more sensitive and specific tandem mass 
spectrometry (LC–MS/MS) for the measurement of A4 
Figure 3
Severity of androgen excess according to diagnosis and serum 
androgen measured for: (A) serum DHEAS, (B) serum 
androstenedione and (C) serum testosterone. Median values 
for each diagnosis are denoted by a solid black or white line. 
Androgen excess levels are represented as ‘fold increase 
above upper limit of normal (ULN)’; levels above ‘1’ therefore 
indicate androgen excess, indicated by the black interrupted 
line. An arbitrary defined cut-off for severe androgen excess 
from 2-fold ULN is indicated by a black dotted line. ACC, 
adrenocortical carcinoma; CAH, congenital adrenal hyperplasia 
(closed circles: classic CAH; open circles: non-classic CAH); CD, 
Cushing’s disease; DoP, disorders of puberty (closed circles: 
central precocious puberty; open circles: isolated premature 
menarche); PA, premature adrenarche; PCOS, polycystic  
ovary syndrome.
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and testosterone. Clinical biochemistry laboratories are 
now using mass spectrometry-based steroid panels with 
increasing frequency, which confronts the clinician often 
with more results than requested in the first place. Our 
findings can provide guidance for risk stratification in the 
assessment of childhood androgen excess.
Only recently, LC–MS/MS-based longitudinal 
measurements of androgens were reported in 40 obese 
girls with adolescent PCOS (33). Interestingly, that study 
reported elevated A4 and testosterone levels, but normal 
DHEAS compared to BMI-matched controls. This is in 
contrast to this study, but also our previous report on pre-
menopausal PCOS women (12), where elevated serum 
DHEAS was the most common finding. We used standard 
reference values obtained from a lean cohort (14), which 
is probably most appropriate for daily clinical practice 
when referring to reference data.
In order to biochemically characterize common 
childhood androgen excess conditions, the patterns 
and severity of androgen levels may help the clinician 
to discriminate non-PA and non-PCOS pathology. 
Children with CAH presented predominantly with A4 
and testosterone excess. Certainly, 17OHP elevation 
would be the key biochemical discriminator to detect 
of the most common form of CAH, 21-hydroxylase 
deficiency, and should be included in the diagnostic 
work-up of childhood androgen excess (1, 7). A basal 
serum 17OHP threshold of 2 ng/mL (6 nmol/L) has been 
shown to distinguish PA from non-classic CAH with high 
sensitivity and specificity (34). All the patients with classic 
CAH in our cohort were on hydrocortisone replacement 
therapy and hence severity and pattern of androgen 
excess will be distinct from androgen excess in newly 
diagnosed CAH patients. However, the serum androgen 
signatures observed in our CAH study sample form a very 
characteristic profile, which is helpful for the clinician in 
interpreting serum androgen profiles to differentiate CAH 
from other disorders associated with androgen excess.
Previous work has provided limited information on 
circulating androgens in girls with central precocious 
puberty (cPP) or IPM. Pubic or axillary hair development 
are rarely part of the spectrum in IPM (35), but have been 
reported in more than 60% of children with cPP (36). All girls 
with cPP (but none of the girls with IPM) in our cohort had 
additional (early) pubarche, which prompted the assessment 
of serum androgens. In our study, all five girls with IPM had 
mild DHEAS excess, which could reflect concomitant (or 
pre-existing) exaggerated adrenarche. Indeed it has been 
shown that higher adrenal androgens are linked to an earlier 
onset of puberty with a shorter peak height velocity (37). 
The underlying etiology of IPM is not well understood, and 
it is considered to be a benign, self-limiting condition (35). 
However, one might speculate that aromatization of excess 
androgens could expose the endometrium to higher levels 
of estrogens, enhancing the build-up of the endometrial 
lining, ultimately resulting in menarche.
ACC is an extremely rare entity in children, apart from 
certain geographical areas like Brazil where ACC is more 
prevalent due to a distinct founder mutation (p.R337H) of 
the TP53 gene (38). The general rarity of ACC is also reflected 
in our study population with a single case diagnosed in 
487 children over a 5-year study period. Interestingly, our 
patient also carried the Brazilian TP53 founder mutation, 
although the family was of South Asian origin. Based 
on a recent larger case series of children with ACC from 
the US (41 cases identified over a period of 60  years), 
androgen excess is the most frequently presenting steroid 
abnormality in childhood ACC (39). Details on serum 
androgen concentrations at presentation, however, are 
not widely reported in childhood ACC, presumably due 
to the rarity of the disease, complicated by historic nature 
of cases and varying assay methodologies. Based on our 
study and what is known from the literature, the findings 
certainly indicate that severe DHEAS excess beyond 8-fold 
ULN should prompt urgent further investigations to 
exclude ACC-related androgen excess.
In conclusion, we have undertaken a detailed analysis 
of pattern and severity of androgen excess in a large 
cohort of children of pre- and post-pubertal age. Our 
findings provide unique insights into the variety and 
frequency of childhood androgen excess conditions and 
the utility of combined measurements of serum DHEAS, 
A4 and testosterone. DHEAS excess is rare in CAH, which 
typically features A4 excess. In contrast, DHEAS excess is 
characteristic for PA and frequently found in adolescent 
PCOS; serum DHEAS increased above 8-fold ULN should 
prompt the clinician to perform further investigations to 
exclude sinister underlying pathology.
Supplementary data
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